JP2024507638A5 - - Google Patents
Info
- Publication number
- JP2024507638A5 JP2024507638A5 JP2023540524A JP2023540524A JP2024507638A5 JP 2024507638 A5 JP2024507638 A5 JP 2024507638A5 JP 2023540524 A JP2023540524 A JP 2023540524A JP 2023540524 A JP2023540524 A JP 2023540524A JP 2024507638 A5 JP2024507638 A5 JP 2024507638A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- sexual
- composition according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026066979A JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142840P | 2021-01-28 | 2021-01-28 | |
| US202163142833P | 2021-01-28 | 2021-01-28 | |
| US63/142,840 | 2021-01-28 | ||
| US63/142,833 | 2021-01-28 | ||
| PCT/US2022/014075 WO2022165017A1 (en) | 2021-01-28 | 2022-01-27 | Use of neuroactive steroids for treatment of sexual dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066979A Division JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507638A JP2024507638A (ja) | 2024-02-21 |
| JP2024507638A5 true JP2024507638A5 (cg-RX-API-DMAC7.html) | 2025-02-03 |
Family
ID=80787167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023540524A Pending JP2024507638A (ja) | 2021-01-28 | 2022-01-27 | 性機能障害処置のための神経刺激性ステロイドの使用 |
| JP2026066979A Pending JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026066979A Pending JP2026120717A (ja) | 2021-01-28 | 2026-04-15 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240122945A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4284382A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024507638A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230136599A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022214187A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3206537A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304080A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008726A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022165017A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| WO2018013613A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| IL309922A (en) * | 2021-07-28 | 2024-03-01 | Sage Therapeutics Inc | Crystalline forms of a neuroactive steroid |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080080094A (ko) * | 2005-10-14 | 2008-09-02 | 하. 룬트벡 아크티에 셀스카브 | 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법 |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| EP3068226A4 (en) * | 2013-11-11 | 2017-05-17 | Euthymics Bioscience, Inc. | Novel methods |
| SI3705488T1 (sl) * | 2014-05-29 | 2022-10-28 | Sage Therapeutics, Inc. | Nevroaktivni steroidi, sestavki in uporaba le-teh |
| PH12018501923B1 (en) * | 2016-03-08 | 2024-06-28 | Sage Therapeutics Inc | Neuroactive steroids, compositions, and uses thereof |
| TW202604538A (zh) | 2016-08-23 | 2026-02-01 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3612186A1 (en) * | 2017-04-18 | 2020-02-26 | Marinus Pharmaceuticals, Inc. | Sustained release injectable neurosteroid formulations |
| WO2019241442A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| MX2021010744A (es) * | 2019-03-04 | 2022-01-18 | Praxis Prec Medicines Inc | Metodos para el tratamiento de la perimenopausia y la menopausia. |
| US20230210870A1 (en) * | 2020-06-08 | 2023-07-06 | Eliem Therapeutics, Inc. | Methods of treating female health conditions related to sex hormones |
-
2022
- 2022-01-27 WO PCT/US2022/014075 patent/WO2022165017A1/en not_active Ceased
- 2022-01-27 EP EP22704661.2A patent/EP4284382A1/en active Pending
- 2022-01-27 IL IL304080A patent/IL304080A/en unknown
- 2022-01-27 US US18/263,189 patent/US20240122945A1/en active Pending
- 2022-01-27 KR KR1020237025051A patent/KR20230136599A/ko active Pending
- 2022-01-27 JP JP2023540524A patent/JP2024507638A/ja active Pending
- 2022-01-27 CA CA3206537A patent/CA3206537A1/en active Pending
- 2022-01-27 MX MX2023008726A patent/MX2023008726A/es unknown
- 2022-01-27 AU AU2022214187A patent/AU2022214187A1/en active Pending
-
2026
- 2026-04-15 JP JP2026066979A patent/JP2026120717A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bartlik et al. | Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors | |
| Damluji et al. | Paradoxical worsening of depressive symptomatology caused by antidepressants | |
| JP2003503450A5 (cg-RX-API-DMAC7.html) | ||
| AR069260A1 (es) | Compuesto 1-[2-(2, 4-dimetilfenilsulfanil)fenil]piperazina.usos terapeuticos de compuestos que tienen actividad combinada de sert (transportador de serotonina), 5-ht3 (receptor 3 de 5-hidroxitriptamina) y 5-ht1a (receptor 1a de 5-hidroxitriptamina).metodo de tratamiento. | |
| KR20230136599A (ko) | 성 기능장애의 치료를 위한 신경활성 스테로이드의용도 | |
| JP2024516297A5 (cg-RX-API-DMAC7.html) | ||
| JP2024515829A5 (cg-RX-API-DMAC7.html) | ||
| AU2004311869A1 (en) | Compositions and methods to treat recurrent medical conditions | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| Ryu et al. | The effects of auricular acupressure therapy on sleep disorder and fatigue in menopausal women | |
| Power-Smith | Beneficial sexual side-effects from fluoxetine | |
| Riley et al. | The effect of single dose diazepam on female sexual response induced by masturbation | |
| JP2009502945A (ja) | 覚醒を改善する方法 | |
| JP2004002474A (ja) | 純粋なフルオキセチンのs(+)異性体を用いる組成物 | |
| JP2005531594A5 (ja) | 慢性痛の治療用トリプルモノアミン再取り込み阻害剤 | |
| US6943193B1 (en) | Method for treating sexual dysfunction | |
| CN1281222C (zh) | 预防和治疗过早射精和/或性兴奋超敏反应的药物组合物 | |
| JP2519148B2 (ja) | うつ病治療剤 | |
| WO2018109935A1 (ja) | Ptsd患者において悪夢を予防、改善、又は治療する薬剤 | |
| US20140148465A1 (en) | Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine | |
| EP0651638A1 (en) | Pharmaceutical composition and method of treatment for serotonin depletion illness | |
| Lim | Initial Management of the Newly Diagnosed PE Patient | |
| RU2440155C1 (ru) | Способ лечения климактерического синдрома | |
| RU2323018C1 (ru) | Способ лечения эректильной дисфункции, ассоциированной с гипертонической болезнью, у больных хроническим простатитом | |
| WO2019172737A1 (ru) | Способ лечения энцефалопатии |